X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/seelos-therapeutics-provides-update-on-top-line-results-from-its-amyotrophic-lateral-sclerosis-als-study-with-sls-005-iv-trehalose-302092918.html
https://www.fiercebiotech.com/biotech/seelos-sugar-molecule-fails-improve-als-disease-severity-midstage-trial
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-receipt-of-minutes-from-its-end-of-phase-ii-meeting-with-the-united-states-food-and-drug-administration-fda-highlighting-modifications-to-the-primary-and-secondary-endpoints-of-its-phase-ii-study-of-302039967.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-inc-releases-letter-to-its-stockholders-302021395.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-closing-of-public-offering-302003489.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-pricing-of-5-55-million-public-offering-302000013.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-proposed-public-offering-301999640.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-the-selection-of-sls-002-intranasal-racemic-ketamine-for-inclusion-in-the-us-department-of-defenses-adaptive-platform-trial-to-evaluate-potential-treatments-for-post-traumatic-stress-disorder-pt-301997327.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-1-for-30-reverse-stock-split-301997234.html
https://www.prnewswire.com/news-releases/seelos-therapeutics-to-present-a-poster-on-sls-005-in-alzheimers-disease-at-neuroscience-2023-301970127.html
Market Place
Share 
